P. Jungers, N. K. Man, and C. , Legendre L'insuffisance rénale chronique : prévention et traitement

P. Nk-man and . Jungers, Principes physico-chimiques de la dialyse, 1994.

M. Lp, Effects of haemoglobin normalization on quality of lif e and cardiov ascular parameters in end-stage renal failure, Nephrol Dial Transplant, vol.15, pp.1425-1455, 2000.

R. Foley, Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy, Kidney International, vol.58, issue.3, pp.1325-1360, 2000.
DOI : 10.1046/j.1523-1755.2000.00289.x

F. Moreno, Quality of life in dialysis patients. A Spanish multicentre study, Nephrology Dialysis Transplantation, vol.11, issue.supp2, pp.125-134, 1996.
DOI : 10.1093/ndt/11.supp2.125

F. Valderrabano, Quality of life benefits of early anaemia treatment, Nephrology Dialysis Transplantation, vol.15, issue.suppl_3, pp.23-31, 2000.
DOI : 10.1093/oxfordjournals.ndt.a027972

R. Moore, Towards long-term graft survival in renal transplantation: the role of erythropoietin, Nephrology Dialysis Transplantation, vol.10, issue.supp1, pp.20-22, 1995.
DOI : 10.1093/ndt/10.supp1.20

T. Linde, Outcome of renal transplantation in patients treated with erythropoietin

E. Vasquez and R. Pollak, EFFECT OF PRETRANSPLANT ERYTHROPOIETIN THERAPY ON RENAL ALLOGRAFT OUTCOME, Transplantation, vol.62, issue.7, pp.1026-1034, 1996.
DOI : 10.1097/00007890-199610150-00024

R. Huch and A. Huch, Maternal and Fetal Erythropoietin: Physiological Aspects and Clinical Significance, Annals of Medicine, vol.82, issue.3
DOI : 10.1172/JCI113564

K. Onoyama, Effects of Human Recombinant Erythropoietin on Anaemia, Systemic Haemodynamics and Renal Function in Predialysis Renal Failure Patients, Nephrology Dialysis Transplantation, vol.4, issue.11, pp.966-70, 1989.
DOI : 10.1093/ndt/4.11.966

B. Becker, Erythropoietin therapy may retard progression in chronic renal transplant dysfunction, Nephrology Dialysis Transplantation, vol.17, issue.9, pp.1667-73, 2002.
DOI : 10.1093/ndt/17.9.1667

J. Eschbach, Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

I. Eidemak, Intravenous versus subcutaneous administration of recombinant human erythropoietin in patients on haemodialysis and CAPD, Nephrol Dial Transplant, vol.7, pp.526-535, 1992.

H. Graf, Novel erythropoiesisstimulating protein (NESP) effectively maintains hemoglobin when administered at a reduced dose frequency compared with recombinant human erythropoietin in dialysis patients

R. Peces, Antibodies against recombinant human erythropoietin in a patient with erythropoietinresistant anemia

H. Bergrem, A case of anti-erythropoietin antibodies following recombinant human erythropietin treatment, Erythropoietin: Molecular Physiology and clinical Application

A. Besarab, The effects of normal as compared with low hematocrit v alues in patients with cardiac disease who are receiv ing hemodialysis and epoetin

J. Woods, Clinical and biochemical correlates of starting ???daily??? hemodialysis, Kidney International, vol.55, issue.6, pp.2467-76, 1999.
DOI : 10.1046/j.1523-1755.1999.00493.x

H. Hirakata, Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis Patients, American Journal of Nephrology, vol.4, issue.6
DOI : 10.1159/000166851

L. Carnitine, une molécule d'avenir dans l'insuffisance cardiaque Synth, Med. Cardiologie, vol.68, pp.19-20, 1991.

F. M. Vaz and R. J. , WANDERS Carnitine biosynthesis in mammals, 417±429 67 -CHARLES J. REBOUCHE Kinetics, Pharmacokinetics, and Regulation of L-Carnitine and Acetyl-L-carnitine Metabolism, 2002.

C. Hoppel, The role of carnitine in normal and altered fatty acid metabolism, American Journal of Kidney Diseases, vol.41, issue.1, pp.4-12
DOI : 10.1016/S0272-6386(03)00112-4

P. Harichaux, Activité physique et carnitine : le mythe et la réalité Méd Sport, pp.197-207, 1994.

S. E. Mills, Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I, Biochemical Journal, vol.214, issue.1, pp.83-91, 1983.
DOI : 10.1042/bj2140083

B. O. Schönekess and G. D. Loparschuk, The effects of carnitine on myocardial carbonhydrate metabolism, pp.39-52, 1995.

I. Tein and D. Mauro, Primary systemic carnitine deficiencey manifested by carnitine-responsive cardiomyopathy, pp.155-184, 1992.

M. Masamura, Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure., Japanese Circulation Journal, vol.54, issue.12, pp.1471-1476, 1990.
DOI : 10.1253/jcj.54.12_1471

D. Donato and S. , Ketogenic response to fasting in human carnitine deficiencies, Clinica Chimica Acta, vol.100, issue.3, pp.209-214, 1980.
DOI : 10.1016/0009-8981(80)90268-5

S. Krähenbühl and J. Reichen, Carnitine metabolism in patients with chronic liver disease, Hepatology, vol.25, issue.1, pp.1579-1599, 1996.
DOI : 10.1053/jhep.1997.v25.pm0008985281

S. Krähenbühl and J. Reichen, Carnitine metabolism in patients with chronic liver disease Hepathology, pp.148-153, 1997.

V. Dolezal and S. Tuceks, Utilization of Citrate, Acetylcarnitine, Acetate, Pyruvate and Glucose for the Synthesis of Acetylcholine in Rat Brain Slices, Journal of Neurochemistry, vol.36, issue.4, pp.1323-1330, 1981.
DOI : 10.1016/0003-2697(78)90080-5

V. Savica, Newer Aspects of Carnitine Metabolism in Uremia, Seminars in Nephrology, vol.26, issue.1, pp.52-55
DOI : 10.1016/j.semnephrol.2005.06.010

?. Rodriguez and S. Segade, Et al Carnitine concentration in dialysed and undialysed patients with chronic renal insufficiency, Ann. Clin. Biochem, vol.25, pp.671-675, 1986.

G. Gilgore and K. Hipp, Physician's L-carnitine hemodialysis utilisation survey Dialisys Transplant, pp.513-516, 1995.

D. Felice and S. , Italy-L-carnitine hemodialisys utilization survey Dialisys Transplant, pp.368-373, 1996.

M. Leschke, Quantitative assessment of carnitine loss dureing hemodialysis and hemofiltration Kidney Int, pp.146-146, 1983.

P. Giovenali, Selective trophic effect of L-carnitine in type I and II a skeletal muscle fibers Kidney Int, pp.1616-1619, 1994.

C. Wanner, Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients, The American Journal of Clinical Nutrition, vol.51, issue.3, pp.407-410, 1990.
DOI : 10.1093/ajcn/51.3.407

C. U. Casciani, et al Beneficial effects of L-carnitine in post-dialysis syndrome, Curr. Ther. Res, vol.32, pp.116-127, 1982.

T. Golper, Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects, Kidney International, vol.38, issue.5, pp.904-911, 1990.
DOI : 10.1038/ki.1990.289

A. Albertazzi, Endocrine metabolic effects of L-carnitine in patients on regular dialysis treatment Proc, EDTA, vol.19, pp.302-307, 1982.

G. Bellinghieri, Correlation between increased serum and tissue L-carnitine levels and improved ùuscle symptoms in hemodialysed patients Am, J. Diet. Assoc, vol.86, pp.644-647, 1983.

M. P. Kooistra, et al The response to recombinant human erythropoietin in patients with anemia of end stage renal disease is correlated with serum carnitine levels Nephron, pp.127-128, 1991.

S. Farrell, Entry of acetyl-l-carnitine into biosynthetic pathways, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.876, issue.1, pp.175-177, 1986.
DOI : 10.1016/0005-2760(86)90332-2

A. Arduini, et al Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability, Life Sci, pp.47-2395, 1990.

A. Arduini, Role of carnitine and carnitine palmitoyltransferase as integral component of the pathwau for membrane phospholipid fatty acid turnover in intact human erythrocytes, J. Biol. Chem, vol.267, pp.12673-12681, 1992.

E. Berard, Low dose of L-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients Nephron, p.145, 1994.

M. Matsumura, Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients Nephron, pp.574-578, 1996.

K. Megri, Effet de la L-carnitine chez les patients en hémodialyse chronique traités par érythropoïétine recombinante Néphrologie, p.171, 1998.

M. Boran, Response to recombinant Human Erythropoietin and L-carnitine combination in patients with anemia of end stage disease Nephron, pp.314-315, 1996.

J. Kletzmayr, Anemia and carnitine supplementation in hemodialyzed patients, Kidney International, vol.55, issue.Suppl. 69, pp.93-106, 2004.
DOI : 10.1046/j.1523-1755.1999.055Suppl.69093.x